A Study to Evaluate Rapid Throughput Screening for Human COVID-19 Infection

NCT04725097 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2821

Last updated 2021-09-09

No results posted yet for this study

Summary

The purpose of this study is to assess the ability of an artificial intelligence smartphone-enabled point of care ECG to detect COVID-19.

Conditions

  • Covid19

Sponsors & Collaborators

Principal Investigators

  • Elie F Berbari, MD · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-10
Primary Completion
2021-06-03
Completion
2021-06-03

Countries

  • United States
  • India
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04725097 on ClinicalTrials.gov